Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today the completion of synthesis for the first two novel

During an official visit of the Translational Genomics Research Institute (TGen) by H.R.H. Prince Guillaume,

Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, announces the appointment of Berndt Modig as

Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation

November 20 – KINAXO Biotechnologies GmbH announces the completion of a financing round, gaining two new investors in the company, Leifina and Conmit Invest. At the same time KINAXO reports that Jürgen Schumacher has been elected as a new member of the company’s advisory board.

November 17th – The 1st user meeting on protein arrays in clinical applications was organized by Protagen, Germany, and focused on the increasing relevance of new markers and marker panels for drug development and therapy. Especially the potential of Protagen’s UNIarray® platform technology for identification and validation of reliable biomarkers for indications like Multiple Sclerosis, [...]

November 09 – TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, has announced that effective October 6, 2009, Dr. Stefan Wohlfeil has

November 09 – Today, TNO, a Dutch contract research organization, and Seventh Wave, an American organization for contract research and consultancy, announce that the companies have

November 9 – QIAGEN N.V. (QGEN) today announced that it has signed a definite agreement to acquire SABiosciences Corporation, a privately-held developer and manufacturer of disease- and pathway-focused PCR assay

Nov. 3 – Cardiac Science Corporation (CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced it will present at the Third Annual Canaccord